Take Solutions Limited (TAKE) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.122x

Based on the latest financial reports, Take Solutions Limited (TAKE) has a cash flow conversion efficiency ratio of -0.122x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-31.39 Million ≈ $-339.47K USD) by net assets (Rs256.29 Million ≈ $2.77 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Take Solutions Limited - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Take Solutions Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read TAKE total liabilities for a breakdown of total debt and financial obligations.

Take Solutions Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Take Solutions Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Grodno S.A.
WAR:GRN
-0.005x
Zakłady Lentex SA
WAR:LTX
0.038x
Globe Metals & Mining Ltd
AU:GBE
-0.048x
Complete Solaria, Inc
NASDAQ:SPWR
0.057x
Nestcon Bhd
KLSE:0235
0.079x
Wiable Corp
KQ:065530
-0.032x
Fuzetec Technology Co Ltd
TWO:6642
0.011x
TECO Image Systems Co Ltd
TWO:5438
-0.017x

Annual Cash Flow Conversion Efficiency for Take Solutions Limited (2007–2025)

The table below shows the annual cash flow conversion efficiency of Take Solutions Limited from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see TAKE stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs205.27 Million
≈ $2.22 Million
Rs-163.66 Million
≈ $-1.77 Million
-0.797x +24.06%
2024-03-31 Rs-88.73 Million
≈ $-959.58K
Rs93.16 Million
≈ $1.01 Million
-1.050x -669.68%
2023-03-31 Rs1.09 Billion
≈ $11.74 Million
Rs200.16 Million
≈ $2.16 Million
0.184x +12.40%
2022-03-31 Rs1.81 Billion
≈ $19.53 Million
Rs296.17 Million
≈ $3.20 Million
0.164x +36.32%
2021-03-31 Rs11.24 Billion
≈ $121.59 Million
Rs1.35 Billion
≈ $14.63 Million
0.120x -9.68%
2020-03-31 Rs15.85 Billion
≈ $171.45 Million
Rs2.11 Billion
≈ $22.83 Million
0.133x +96.40%
2019-03-31 Rs15.27 Billion
≈ $165.18 Million
Rs1.04 Billion
≈ $11.20 Million
0.068x -25.00%
2018-03-31 Rs13.37 Billion
≈ $144.56 Million
Rs1.21 Billion
≈ $13.07 Million
0.090x +54.17%
2017-03-31 Rs9.53 Billion
≈ $103.08 Million
Rs558.98 Million
≈ $6.05 Million
0.059x -73.41%
2016-03-31 Rs6.72 Billion
≈ $72.62 Million
Rs1.48 Billion
≈ $16.02 Million
0.221x +72.74%
2015-03-31 Rs5.80 Billion
≈ $62.78 Million
Rs741.25 Million
≈ $8.02 Million
0.128x -33.69%
2014-03-31 Rs5.18 Billion
≈ $56.06 Million
Rs998.25 Million
≈ $10.80 Million
0.193x -23.03%
2013-03-31 Rs4.66 Billion
≈ $50.41 Million
Rs1.17 Billion
≈ $12.61 Million
0.250x -17.75%
2012-03-31 Rs3.80 Billion
≈ $41.05 Million
Rs1.15 Billion
≈ $12.49 Million
0.304x +45.36%
2011-03-31 Rs2.82 Billion
≈ $30.48 Million
Rs589.85 Million
≈ $6.38 Million
0.209x +341.83%
2010-03-31 Rs3.86 Billion
≈ $41.70 Million
Rs182.63 Million
≈ $1.98 Million
0.047x -72.58%
2009-03-31 Rs3.86 Billion
≈ $41.73 Million
Rs666.62 Million
≈ $7.21 Million
0.173x +1.88%
2008-03-31 Rs2.98 Billion
≈ $32.28 Million
Rs506.13 Million
≈ $5.47 Million
0.170x +25.11%
2007-03-31 Rs885.44 Million
≈ $9.58 Million
Rs120.02 Million
≈ $1.30 Million
0.136x --

About Take Solutions Limited

NSE:TAKE India Biotechnology
Market Cap
$67.51 Million
Rs6.24 Billion INR
Market Cap Rank
#20714 Global
#1124 in India
Share Price
Rs42.69
Change (1 day)
-2.00%
52-Week Range
Rs7.31 - Rs50.14
All Time High
Rs293.99
About

TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient c… Read more